How do I draw 12.5 units
In June 2021, the US Food and Drug Administration (FDA) approved semaglutide for chronic weight management in adults with a body mass index (BMI) of 277 or greater who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Common side effects include mild nausea or digestive discomfort, which usually subside as your body adapts to the treatment
Patients with a history of gastrointestinal disorders may be at higher risk of experiencing these symptoms, and Ozempic is not recommended in severe gastrointestinal disease (e.g., severe gastroparesis)
The most common side effects of semaglutide include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn and gastroparesis or stomach paralysis